| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Signalling Laboratory (I.F., G.R., R.F., G.C.G., M.Y.F., A.M.M., L.C.), Department of Human Anatomical Science, University of Bologna, 40126 Bologna, Italy; Laboratory of Cell Biology and Electron Microscopy (A.B.), Istituti Ortopedici Rizzoli, 40136 Bologna, Italy; Department of Pathology (R.S.G.), University of Cambridge, Cambridge CB2 1QP, United Kingdom; and Departments of Biochemistry and Medicine and Whitaker Cardiovascular Institute (K.R.), Boston University School of Medicine, Boston, Massachusetts 02118
Address all correspondence and requests for reprints to: Dr. Lucio Cocco, Cellular Signalling Laboratory, Department of Human Anatomical Sciences, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy. E-mail: lcocco{at}biocfarm.unibo.it.
Our main goal in this study was to investigate the role of phospholipase C (PLC) ß1 and PLC
1 in skeletal muscle differentiation and the existence of potential downstream targets of their signaling activity. To examine whether PLC signaling can modulate the expression of cyclin D3, a target of PLCß1 in erythroleukemia cells, we transfected C2C12 cells with expression vectors containing PLCß1 or PLC
1 cDNA and with small interfering RNAs from regions of the PLCß1 or PLC
1 gene and followed myogenic differentiation in this well-established cell system. Intriguingly, overexpressed PLCß1 and PLC
1 were able to mimic insulin induction of both cyclin D3 and muscle differentiation. By knocking down PLCß1 or PLC
1 expression, C2C12 cells almost completely lost the increase in cyclin D3, and the differentiation program was down-regulated. To explore the induction of the cyclin D3 gene promoter during this process, we used a series of 5'-deletions of the 1.68-kb promoter linked to a reporter gene and noted a 5-fold augmentation of promoter activity upon insulin stimulation. These constructs were also cotransfected with PLCß1 or PLC
1 cDNAs and small interfering RNAs, respectively. Our data indicate that PLCß1 or PLC
1 signaling is capable of acting like insulin in regard to both the myogenic differentiation program and cyclin D3 up-regulation. Taken together, this is the first study that hints at cyclin D3 as a target of PLCß1 and PLC
1 during myogenic differentiation in vitro and implies that up-regulation of these enzymes is sufficient to mimic the actions of insulin in this process.
This article has been cited by other articles:
![]() |
Y. Ding, K. J. Choi, J. H. Kim, X. Han, Y. Piao, J.-H. Jeong, W. Choe, I. Kang, J. Ha, H. J. Forman, et al. Endogenous Hydrogen Peroxide Regulates Glutathione Redox via Nuclear Factor Erythroid 2-Related Factor 2 Downstream of Phosphatidylinositol 3-Kinase during Muscle Differentiation Am. J. Pathol., June 1, 2008; 172(6): 1529 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. De Santa, S. Albini, E. Mezzaroma, L. Baron, A. Felsani, and M. Caruso pRb-Dependent Cyclin D3 Protein Stabilization Is Required for Myogenic Differentiation Mol. Cell. Biol., October 15, 2007; 27(20): 7248 - 7265. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Evangelisti, P. L. Tazzari, M. Riccio, R. Fiume, Y. Hozumi, F. Fala, K. Goto, L. Manzoli, L. Cocco, and A. M. Martelli Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts FASEB J, October 1, 2007; 21(12): 3297 - 3307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lim, K. J. Choi, Y. Ding, J. H. Kim, B. S. Kim, Y. H. Kim, J. Lee, W. Choe, I. Kang, J. Ha, et al. RhoA/Rho Kinase Blocks Muscle Differentiation via Serine Phosphorylation of Insulin Receptor Substrate-1 and -2 Mol. Endocrinol., September 1, 2007; 21(9): 2282 - 2293. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |